About Tetradrip Pharma Private Limited
Data last updated:
Tetradrip Pharma Private Limited is a private limited company based in Burdwan, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 April 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U33111WB2013PTC192301. Its GSTIN is 19AAECT5982D1Z1 (West Bengal).
The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹6.19 Cr. It is led by directors Manoj Gupta and Swati Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Vill P.O. – Barakashiara Dist. – Burdwan, West Bengal, India – 713141.
As per the financials filed for FY 2024, the company reported a revenue of ₹21.18 Cr, a growth of 91% compared to the previous year. For the same year it recorded a net profit of ₹18.97 Lakh (net margin 0.9%) and EBITDA of ₹97.51 Lakh (EBITDA margin 4.6%). Revenue has grown at a compounded annual rate (CAGR) of 150% over three years and 84% over five years.
The company has about 69 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3.8 Cr and satisfied charges of ₹4.23 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmaimpexlab.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressVill P.O. – Barakashiara Dist. – Burdwan, West Bengal, India – 713141
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Tetradrip Pharma Private Limited
The main business activity of Tetradrip Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Tetradrip Pharma Private Limited FY 2024 filings available
Tetradrip Pharma Private Limited reported revenue of ₹21.18 Cr (up 91% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Tetradrip Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 84% over five years, including 91% growth in the latest year. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Tetradrip Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹97.51 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹18.97 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Tetradrip Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Tetradrip Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Tetradrip Pharma Private Limited
Tetradrip Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Marxx Pharma Private Limited | ₹21.23 Cr (FY 2024) | •••• | •••• | 682.0% | •••• | Hisar, Haryana, India |
| Ravi Pharmaceuticals Pvt Ltd | ₹21.23 Cr (FY 2024) | •••• | •••• | 15.0% | •••• | Khambhat, Gujarat, India |
| Glowsun India Labs Private Limited | ₹21.2 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Dehradun, Uttarakhand, India |
| Ethicare Pharmaceuticals Private Limited | ₹21.2 Cr (FY 2025) | •••• | •••• | 94.0% | •••• | Vadodara, Gujarat, India |
| Akul Industries Private Limited | ₹21.18 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Patna, Bihar, India |
| Tetradrip Pharma Private Limited this company | ₹21.18 Cr (FY 2024) | •••• | •••• | 91.0% | •••• | Burdwan, West Bengal, India |
| Aurum Lifesciences Private Limited | ₹21.14 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Vadodara, Gujarat, India |
| Zenasia Life Sciences Private Limited | ₹21.14 Cr (FY 2025) | •••• | •••• | 105.0% | •••• | Sangareddy, Telangana, India |
| Avance Healthcare Private Limited | ₹21.12 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Rajkot, Gujarat, India |
| Ishaanav Nutraceuticals Private Limited | ₹21.09 Cr (FY 2024) | •••• | •••• | 28.0% | •••• | Dehradun, Uttarakhand, India |
| Suvik Hitek Pvt Ltd | ₹21.09 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Tetradrip Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Tetradrip Pharma Private Limited
Tetradrip Pharma Private Limited is audited by Dangi Jain & Company for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Dangi Jain & Company | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Tetradrip Pharma Private Limited
Tetradrip Pharma has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Gupta | Director | 06 Dec 2019 | 6 Years 10 Months | Current |
| Swati Gupta | Director | 06 Dec 2019 | 6 Years 10 Months | Current |
Ownership and Shareholding of Tetradrip Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Tetradrip Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Nov 2025 | State Bank of India | ₹3.8 Cr | Open |
| 27 Aug 2015 | Others | ₹4.23 Cr | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Tetradrip Pharma Private Limited
Tetradrip Pharma Private Limited has 1 court case on record: 1 filed by Tetradrip Pharma. All case is pending. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Calcutta High Court | Writ petition | Filed by the company against State of West Bengal | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Tetradrip Pharma Private Limited
Tetradrip Pharma Private Limited has a workforce of 69 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Tetradrip Pharma Private Limited
Tetradrip Pharma Private Limited has 9 board changes on record since 2019: 2 appointments and 7 cessations. The latest: Arvind Khaitan ceased to be Director on 03 Sep 2021.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Tetradrip Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Tetradrip Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Tetradrip Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Tetradrip Pharma Private Limited
Tetradrip Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAECT5982D1Z1 | West Bengal | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Tetradrip Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tetradrip Pharma Private Limited
Tetradrip Pharma is an active private limited company based in Burdwan, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 April 2013 (13+ years old) and is registered under CIN U33111WB2013PTC192301.
Tetradrip Pharma reported revenue of ₹21.18 Cr for FY 2024 (up 91% YoY).
Tetradrip Pharma has 2 current directors:
- Manoj Gupta - Director
- Swati Gupta - Director
Tetradrip Pharma reported a net profit of ₹18.97 Lakh (net margin 0.9%) and EBITDA of ₹97.51 Lakh (EBITDA margin 4.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Tetradrip Pharma is 150% over three years and 84% over five years. In the latest year (FY 2024) revenue rose 91%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Tetradrip Pharma is 19AAECT5982D1Z1, registered in West Bengal.
The CIN (Corporate Identification Number) of Tetradrip Pharma is U33111WB2013PTC192301. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tetradrip Pharma has 1 court case on record: 1 filed by the company. 1 is pending.
Tetradrip Pharma was incorporated on 17 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Tetradrip Pharma by revenue are Marxx Pharma Private Limited, Ravi Pharmaceuticals Pvt Ltd, Glowsun India Labs Private Limited, Ethicare Pharmaceuticals Private Limited, Akul Industries Private Limited and 5 more, all in the Pharma industry (Formulations).
Arvind Khaitan ceased to be Director on 03 Sep 2021. Abhishek Saraogi ceased to be Director on 30 Aug 2021. Manoj Gupta ceased to be Additional Director on 17 Dec 2020. Tetradrip Pharma has 9 board changes on record in total.